6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid

C198H199BrCl6F9N51O40 — CID 160820728

IUPAC6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid
SMILESCC1(F)CN(C(=O)CBr)C1.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2[nH]c1=O.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2n(CC(=O)N2CC(C)(F)C2)c1=O.CCOc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)O)c(=O)n2CC(=O)N1CC(C)(F)C1.COc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C26H26ClFN6O4.C25H24ClFN6O4.C25H24ClFN6O3.C24H22ClFN6O3.C23H22ClFN6O5.C23H24ClFN6O3.C18H20FN5O6.C16H16FN5O6.C12H12N4O5.C6H9BrFNO/c1-4-38-25-31-19-11-29-22-17(21(19)32(25)3)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)33-13-26(2,28)14-33;1-25(27)12-32(13-25)19(34)11-33-21-16(20-18(10-28-21)30-24(37-3)31(20)2)8-17(23(33)36)22(35)29-9-14-4-6-15(26)7-5-14;1-14-30-19-10-28-22-17(21(19)31(14)3)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-24(26)11-31(12-24)19(33)10-32-21-16(20-18(9-27-21)29-13-30(20)2)7-17(23(32)35)22(34)28-8-14-3-5-15(25)6-4-14;1-23(25)11-29(12-23)18(32)10-30-20-15(19(26-2)17(9-27-20)31(35)36)7-16(22(30)34)21(33)28-8-13-3-5-14(24)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13;1-4-30-17(27)11-5-10-14(20-3)12(24(28)29)6-21-15(10)23(16(11)26)7-13(25)22-8-18(2,19)9-22;1-16(17)6-20(7-16)11(23)5-21-13-8(3-9(14(21)24)15(25)26)12(18-2)10(4-19-13)22(27)28;1-3-21-12(18)7-4-6-9(13-2)8(16(19)20)5-14-10(6)15-11(7)17;1-6(8)3-9(4-6)5(10)2-7/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);4-8,10H,9,11-13H2,1-3H3,(H,29,35);4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9,13H,8,10-12H2,1-2H3,(H,28,34);3-7,9H,8,10-12H2,1-2H3,(H,26,27)(H,28,33);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33);5-6H,4,7-9H2,1-3H3,(H,20,21);3-4H,5-7H2,1-2H3,(H,18,19)(H,25,26);4-5H,3H2,1-2H3,(H2,13,14,15,17);2-4H2,1H3
InChIKeySFMYWZMOVPEHPQ-UHFFFAOYSA-N
MW4396.69 g/mol
LogP18.85
Rot. Bonds52

About 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid

6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid (PubChem CID 160820728) has the molecular formula C198H199BrCl6F9N51O40 and a molecular weight of 4396.69 g/mol. Its IUPAC name is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid.

Molecular Properties

Compound Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid
PubChem CID160820728
Molecular FormulaC198H199BrCl6F9N51O40
Molecular Weight4396.69 g/mol
Exact Mass4390.23
IUPAC Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid
SMILESCC1(F)CN(C(=O)CBr)C1.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2[nH]c1=O.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2n(CC(=O)N2CC(C)(F)C2)c1=O.CCOc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)O)c(=O)n2CC(=O)N1CC(C)(F)C1.COc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C26H26ClFN6O4.C25H24ClFN6O4.C25H24ClFN6O3.C24H22ClFN6O3.C23H22ClFN6O5.C23H24ClFN6O3.C18H20FN5O6.C16H16FN5O6.C12H12N4O5.C6H9BrFNO/c1-4-38-25-31-19-11-29-22-17(21(19)32(25)3)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)33-13-26(2,28)14-33;1-25(27)12-32(13-25)19(34)11-33-21-16(20-18(10-28-21)30-24(37-3)31(20)2)8-17(23(33)36)22(35)29-9-14-4-6-15(26)7-5-14;1-14-30-19-10-28-22-17(21(19)31(14)3)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-24(26)11-31(12-24)19(33)10-32-21-16(20-18(9-27-21)29-13-30(20)2)7-17(23(32)35)22(34)28-8-14-3-5-15(25)6-4-14;1-23(25)11-29(12-23)18(32)10-30-20-15(19(26-2)17(9-27-20)31(35)36)7-16(22(30)34)21(33)28-8-13-3-5-14(24)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13;1-4-30-17(27)11-5-10-14(20-3)12(24(28)29)6-21-15(10)23(16(11)26)7-13(25)22-8-18(2,19)9-22;1-16(17)6-20(7-16)11(23)5-21-13-8(3-9(14(21)24)15(25)26)12(18-2)10(4-19-13)22(27)28;1-3-21-12(18)7-4-6-9(13-2)8(16(19)20)5-14-10(6)15-11(7)17;1-6(8)3-9(4-6)5(10)2-7/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);4-8,10H,9,11-13H2,1-3H3,(H,29,35);4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9,13H,8,10-12H2,1-2H3,(H,28,34);3-7,9H,8,10-12H2,1-2H3,(H,26,27)(H,28,33);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33);5-6H,4,7-9H2,1-3H3,(H,20,21);3-4H,5-7H2,1-2H3,(H,18,19)(H,25,26);4-5H,3H2,1-2H3,(H2,13,14,15,17);2-4H2,1H3
InChIKeySFMYWZMOVPEHPQ-UHFFFAOYSA-N
XLogP18.85
TPSA1120.63 Ų
H-Bond Donors14
H-Bond Acceptors70
Rotatable Bonds52
Heavy Atoms305
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004396.69
LogP ≤ 518.85
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1070

Analyze 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid (CID 160820728) is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid.
What is the SMILES notation for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The canonical SMILES for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid is CC1(F)CN(C(=O)CBr)C1.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2[nH]c1=O.CCOC(=O)c1cc2c(NC)c([N+](=O)[O-])cnc2n(CC(=O)N2CC(C)(F)C2)c1=O.CCOc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.CNc1c([N+](=O)[O-])cnc2c1cc(C(=O)O)c(=O)n2CC(=O)N1CC(C)(F)C1.COc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.
What is the InChIKey of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid?
The InChIKey is SFMYWZMOVPEHPQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26ClFN6O4.C25H24ClFN6O4.C25H24ClFN6O3.C24H22ClFN6O3.C23H22ClFN6O5.C23H24ClFN6O3.C18H20FN5O6.C16H16FN5O6.C12H12N4O5.C6H9BrFNO/c1-4-38-25-31-19-11-29-22-17(21(19)32(25)3)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)33-13-26(2,28)14-33;1-25(27)12-32(13-25)19(34)11-33-21-16(20-18(10-28-21)30-24(37-3)31(20)2)8-17(23(33)36)22(35)29-9-14-4-6-15(26)7-5-14;1-14-30-19-10-28-22-17(21(19)31(14)3)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-24(26)11-31(12-24)19(33)10-32-21-16(20-18(9-27-21)29-13-30(20)2)7-17(23(32)35)22(34)28-8-14-3-5-15(25)6-4-14;1-23(25)11-29(12-23)18(32)10-30-20-15(19(26-2)17(9-27-20)31(35)36)7-16(22(30)34)21(33)28-8-13-3-5-14(24)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13;1-4-30-17(27)11-5-10-14(20-3)12(24(28)29)6-21-15(10)23(16(11)26)7-13(25)22-8-18(2,19)9-22;1-16(17)6-20(7-16)11(23)5-21-13-8(3-9(14(21)24)15(25)26)12(18-2)10(4-19-13)22(27)28;1-3-21-12(18)7-4-6-9(13-2)8(16(19)20)5-14-10(6)15-11(7)17;1-6(8)3-9(4-6)5(10)2-7/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);4-8,10H,9,11-13H2,1-3H3,(H,29,35);4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9,13H,8,10-12H2,1-2H3,(H,28,34);3-7,9H,8,10-12H2,1-2H3,(H,26,27)(H,28,33);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33);5-6H,4,7-9H2,1-3H3,(H,20,21);3-4H,5-7H2,1-2H3,(H,18,19)(H,25,26);4-5H,3H2,1-2H3,(H2,13,14,15,17);2-4H2,1H3.
What are the key properties of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid?
6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid has a molecular weight of 4396.69 g/mol, XLogP of 18.85, 52 rotatable bonds, 14 hydrogen bond donors, and 70 hydrogen bond acceptors.
Where does this data come from?
All data for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-bromo-1-(3-fluoro-3-methylazetidin-1-yl)ethanone;N-[(4-chlorophenyl)methyl]-2-ethoxy-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methoxy-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;ethyl 1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylate;ethyl 5-(methylamino)-6-nitro-2-oxo-1H-1,8-naphthyridine-3-carboxylate;1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-6-nitro-2-oxo-1,8-naphthyridine-3-carboxylic acid is sourced from PubChem (CID 160820728), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).